Terms: = Kidney tumors AND TG, Thyroglobulin
167 results:
1. The association between the triglyceride-glucose index and prognosis in postoperative renal cell carcinoma patients: a retrospective cohort study.
Qin G; Sun Z; Jin Y; Ren X; Zhang Z; Wang S; Zhou G; Huang K; Zhao H; Jiang X
Front Endocrinol (Lausanne); 2024; 15():1301703. PubMed ID: 38476671
[TBL] [Abstract] [Full Text] [Related]
2. Mucin-1-Targeted Chimeric Antigen Receptor T Cells Are Effective and Safe in Controlling Solid tumors in Immunocompetent Host.
Zhou R; Wu ST; Yazdanifar M; Williams C; Sanders A; Brouwer C; Maher J; Mukherjee P
J Immunother; 2024 Apr; 47(3):77-88. PubMed ID: 38270462
[TBL] [Abstract] [Full Text] [Related]
3. Evaluation of the Carcinogenic Potential of Enarodustat (JTZ-951), a Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor, in 26-Week Tg.rasH2 Mouse Study and 2-Year Sprague-Dawley Rat Study.
Kemmochi Y; Toyoda K; Ishida T; Yasui Y; Shoda T
Int J Toxicol; 2023 Dec; 42(6):489-503. PubMed ID: 37480334
[TBL] [Abstract] [Full Text] [Related]
4. Preexisting autoantibodies as predictor of immune related adverse events (irAEs) for advanced solid tumors treated with immune checkpoint inhibitors (ICIs).
Daban A; Gonnin C; Phan L; Saldmann A; Granier C; Lillo-Lelouet A; Le Beller C; Pouchot J; Weiss L; Tartour E; Fabre E; Medioni J; Oudard S; Vano YA; Dragon-Durey MA; Simonaggio A
Oncoimmunology; 2023; 12(1):2204754. PubMed ID: 37187974
[TBL] [Abstract] [Full Text] [Related]
5. Cancer in Ecuadorian subjects with Laron syndrome (ELS).
Guevara-Aguirre J; Peña G; Pazmiño G; Acosta W; Saavedra J; Lescano D; Guevara A; Gavilanes AWD
Endocr Relat Cancer; 2023 Jun; 30(6):. PubMed ID: 36971780
[TBL] [Abstract] [Full Text] [Related]
6. Clear evidence of the carcinogenic potential of anthracene: A 2-year feeding study in rats and mice.
Takeda T; Suzuki M; Kano H; Matsumoto M; Umeda Y
Environ Toxicol; 2023 Mar; 38(4):709-726. PubMed ID: 36478108
[TBL] [Abstract] [Full Text] [Related]
7. HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans.
Ma Y; Joyce A; Brandenburg O; Saatchi F; Stevens C; Toffessi Tcheuyap V; Christie A; Do QN; Fatunde O; Macchiaroli A; Wong SC; Woolford L; Yousuf Q; Miyata J; Carrillo D; Onabolu O; McKenzie T; Mishra A; Hardy T; He W; Li D; Ivanishev A; Zhang Q; Pedrosa I; Kapur P; Schluep T; Kanner SB; Hamilton J; Brugarolas J
Clin Cancer Res; 2022 Dec; 28(24):5405-5418. PubMed ID: 36190432
[TBL] [Abstract] [Full Text] [Related]
8. Differential expression profiling of onco and tumor-suppressor genes from major-signaling pathways in Wilms' tumor.
Sahu DK; Singh N; Das M; Rawat J; Gupta DK
Pediatr Surg Int; 2022 Nov; 38(11):1601-1617. PubMed ID: 36107237
[TBL] [Abstract] [Full Text] [Related]
9. ImmunoPET Imaging with 89Zr-Labeled Atezolizumab Enables In Vivo Evaluation of PD-L1 in Tumorgraft Models of Renal Cell Carcinoma.
Mulgaonkar A; Elias R; Woolford L; Guan B; Nham K; Kapur P; Christie A; Tcheuyap VT; Singla N; Bowman IA; Stevens C; Hao G; Brugarolas J; Sun X
Clin Cancer Res; 2022 Nov; 28(22):4907-4916. PubMed ID: 36074149
[TBL] [Abstract] [Full Text] [Related]
10. A Randomized Study on the Effect of Metformin Combined with Intensive-Exercise Diet Therapy on Glucose and Lipid Metabolism and Islet Function in Patients with Renal Cell Carcinoma and Diabetes.
Liu Y; Meng LL; Li JW; Jin YS; An RH
Dis Markers; 2022; 2022():7383745. PubMed ID: 35872697
[TBL] [Abstract] [Full Text] [Related]
11. Membranous Nephropathy Secondary to Graves' Disease: A Case Report.
Neves PDMM; Muniz MPR; Morgantetti GF; Cutrim ÉMM; Macieira CA; Salgado-Filho N; Lages JS; Brito DJA; Cunha KA; Gatto GC; Silva GEB
Front Immunol; 2022; 13():824124. PubMed ID: 35734176
[TBL] [Abstract] [Full Text] [Related]
12. Higher genetically predicted low-density lipoprotein levels increase the renal cancer risk independent of triglycerides and high-density lipoprotein levels: A Mendelian randomization study.
Ma Y; Jian Z; Xiang L; Jin X
Int J Cancer; 2022 Aug; 151(4):518-525. PubMed ID: 35429337
[TBL] [Abstract] [Full Text] [Related]
13. Metastatic Clear Cell Renal Cell Carcinoma Involving the Thyroid Gland: A Clinicopathologic Study of 17 Patients.
Velez Torres JM; Briski LM; Martinez Duarte E; Sadow PM; Kerr DA; Kryvenko ON
Int J Surg Pathol; 2022 Oct; 30(7):743-752. PubMed ID: 35253524
[No Abstract] [Full Text] [Related]
14. Late-Onset Metastatic Renal Cell Carcinoma to the Thyroid Gland: An Unusual Airway Emergency.
Abdul-Hadi S; Beauchamp FD; Cheverez-Ocasio J; Pascual-Marrero J; Portela-Arraiza JC; Correa-Rivas M
Am J Case Rep; 2022 Feb; 23():e934814. PubMed ID: 35165252
[TBL] [Abstract] [Full Text] [Related]
15. A renal cell carcinoma tumorgraft platform to advance precision medicine.
Elias R; Tcheuyap VT; Kaushik AK; Singla N; Gao M; Reig Torras O; Christie A; Mulgaonkar A; Woolford L; Stevens C; Kettimuthu KP; Pavia-Jimenez A; Boroughs LK; Joyce A; Dakanali M; Notgrass H; Margulis V; Cadeddu JA; Pedrosa I; Williams NS; Sun X; DeBerardinis RJ; Öz OK; Zhong H; Seshagiri S; Modrusan Z; Cantarel BL; Kapur P; Brugarolas J
Cell Rep; 2021 Nov; 37(8):110055. PubMed ID: 34818533
[TBL] [Abstract] [Full Text] [Related]
16. Revealing potential lipid biomarkers in clear cell renal cell carcinoma using targeted quantitative lipidomics.
Li W; Wang X; Zhang X; Gong P; Ding D; Wang N; Wang Z
Lipids Health Dis; 2021 Nov; 20(1):160. PubMed ID: 34774030
[TBL] [Abstract] [Full Text] [Related]
17. Time-gated Raman spectroscopy and proteomics analyses of hypoxic and normoxic renal carcinoma extracellular vesicles.
Samoylenko A; Kögler M; Zhyvolozhnyi A; Makieieva O; Bart G; Andoh SS; Roussey M; Vainio SJ; Hiltunen J
Sci Rep; 2021 Oct; 11(1):19594. PubMed ID: 34599227
[TBL] [Abstract] [Full Text] [Related]
18. High concentrations of triglycerides are associated with diabetic kidney disease in new-onset type 2 diabetes in China: Findings from the China Cardiometabolic Disease and Cancer Cohort (4C) Study.
Gong L; Wang C; Ning G; Wang W; Chen G; Wan Q; Qin G; Yan L; Wang G; Qin Y; Luo Z; Tang X; Huo Y; Hu R; Ye Z; Shi L; Gao Z; Su Q; Mu Y; Zhao J; Chen L; Zeng T; Yu X; Li Q; Shen F; Zhang Y; Wang Y; Deng H; Liu C; Wu S; Yang T; Bi Y; Lu J; Li M; Xu Y; Xu M; Wang T; Zhao Z; Hou X; Chen L
Diabetes Obes Metab; 2021 Nov; 23(11):2551-2560. PubMed ID: 34322974
[TBL] [Abstract] [Full Text] [Related]
19. Staging childhood cancers in Europe: Application of the Toronto stage principles for neuroblastoma and Wilms tumour. The JARC pilot study.
Gatta G; Botta L; Capocaccia R; Cañete A; Pritchard-Jones K;
Pediatr Blood Cancer; 2021 Sep; 68(9):e29020. PubMed ID: 34114308
[TBL] [Abstract] [Full Text] [Related]
20. EWSR1-PATZ1 fusion renal cell carcinoma: a recurrent gene fusion characterizing thyroid-like follicular renal cell carcinoma.
Al-Obaidy KI; Bridge JA; Cheng L; Sumegi J; Reuter VE; Benayed R; Hameed M; Williamson SR; Hes O; Alruwaii FI; Segal JP; Wanjari P; Idrees MT; Nassiri M; Eble JN; Grignon DJ
Mod Pathol; 2021 Oct; 34(10):1921-1934. PubMed ID: 34099871
[TBL] [Abstract] [Full Text] [Related]
[Next]
